(Q35028773)

5 August 2017

title

Branch retinal vein occlusion: treatment modalities: an update of the literature (English)

1 reference

5 August 2017

main subject

retinal vein occlusion

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171809%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Irini P Chatziralli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171809%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Vasileios G Peponis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171809%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Panagiotis G Mitropoulos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171809%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Marilita M Moschos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171809%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

English

0 references

publication date

30 October 2013

1 reference

Seminars in Ophthalmology

5 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171809%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171809%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171809%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

85-107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171809%20AND%20SRC:MED&resulttype=core&format=json

Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Branch retinal vein occlusion: classification and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Retinal and orbital venous occlusions treated with enoxaparin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Interventions for branch retinal vein occlusion: an evidence-based systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Arteriovenous crossing dissection without separation of the retina vessels for treatment of branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Sheathotomy to decompress branch retinal vein occlusion: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Arteriovenous sheathotomy in venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Transvitreal limited arteriovenous-crossing manipulation without vitrectomy for complicated branch retinal vein occlusion using 25-gauge instrumentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Effect of arteriovenous sheathotomy on retinal blood flow and macular edema in patients with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Arterio-venous dissection after isovolaemic haemodilution in branch retinal vein occlusion: a non-randomised prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Arteriovenous sheathotomy for persistent macular edema in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Sheathotomy in complicated cases of branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Visual acuity and multifocal electroretinographic changes after arteriovenous crossing sheathotomy for macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Long-term visual outcome of arteriovenous adventitial sheathotomy on branch retinal vein occlusion induced macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Arteriovenous crossing sheathotomy in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Combined arteriovenous sheathotomy and intraoperative intravitreal triamcinolone acetonide for branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Macular edema from distant branch retinal vein occlusion improved after vitrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: a study by the Japanese BRVO study group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Efficacy of vitrectomy and internal limiting membrane removal for macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

25-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic cystoid macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Vitrectomy alone versus vitrectomy with simultaneous intravitreal injection of triamcinolone for macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Grid laser treatment in macular branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Grid laser treatment of macular edema in macular branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Argon laser scatter photocoagulation in treatment of branch retinal vein occlusion. A prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Short-duration focal pattern grid photocoagulation for macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Management of retinal vein occlusion--consensus document.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Retinal vein occlusion: current treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Trans-tenon retrobulbar triamcinolone infusion for chronic macular edema in central and branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Bilateral retinal venous occlusion and unilateral cystoid macular edema in Churg-Strauss syndrome treated with intravitreal triamcinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Early versus late intravitreal triamcinolone acetonide for macular edema associated with branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Trans-tenon retrobulbar triamcinolone injection for macular edema associated with branch retinal vein occlusion remaining after vitrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Pegaptanib for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Pegaptanib sodium for macular edema secondary to central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Pegaptanib for branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Rapid regression of extensive retinovitreal neovascularization secondary to branch retinal vein occlusion after a single intravitreal injection of bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Bevacizumab in retinal vein occlusion-results of a prospective case series

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Treatment of branch retinal vein occlusion induced macular edema with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion:results after 12 months and multiple regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Results of bevacizumab as the primary treatment for retinal vein occlusions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal bevacizumab treatment for macular edema due to branch retinal vein occlusion in a clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Grid laser photocoagulation for macular oedema due to branch retinal vein occlusion in the age of bevacizumab? Results of a prospective study with crossover design

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271

Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.833271